deltatrials
Completed PHASE4 NCT00623987

Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants

Absence of Residual Vein Thrombosis After an Episode of Unprovoked Deep Vein Thrombosis: Short-Term Anticoagulation is Safe.

Sponsor: Azienda Ospedaliera Universitaria Policlinico

Conditions Deep Vein Thrombosis
Interventions warfarin accordingly INR value
Updated 5 times since 2017 Last updated: Mar 24, 2008 Started: Jun 30, 1999 Primary completion: Jun 30, 2006 Completion: Jan 31, 2008

Listed as NCT00623987, this PHASE4 trial focuses on Deep Vein Thrombosis and remains completed. Sponsored by Azienda Ospedaliera Universitaria Policlinico, it has been updated 5 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Jun 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Azienda Ospedaliera Universitaria Policlinico
Data source: Azienda Ospedaliera Universitaria Policlinico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Palermo, Italy